Elevation Oncology, Inc.(ELEV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ELEV Elevation Oncology, Inc.

停牌 09-03 10:25:20 EDT

0.3650

+0.0000

0.00%

最高0.3650	最低0.3650	成交量0.00
今开0.3650	昨收0.3650	日振幅0.00%
总市值2,163万	流通市值1,589万	总股本5,925万
成交额0.00	换手率0.00%	流通股本4,353万
市净率0.46	ROE-78.32%	每股收益-0.81
52周最高3.09	52周最低0.2210	市盈率-0.45
股息0.00	股息收益率0.00	ROA-29.86%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ELEV","market":"US","secType":"STK","nameCN":"Elevation Oncology, Inc.","latestPrice":0.365,"timestamp":1756909518129,"preClose":0.365,"halted":3,"volume":0,"delay":0,"floatShares":43534820,"shares":59252879,"eps":-0.811777,"marketStatus":"停牌","change":0,"latestTime":"09-03 10:25:18 EDT","open":0.365,"high":0.365,"low":0.365,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.811777,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1756929600000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":0.365,"volumeRatio":0},"requestUrl":"/m/hq/s/ELEV","defaultTab":"news","newsList":[{"id":"2546372960","title":"Elevation Oncology, Inc.盘中异动 股价大跌5.90%报0.362美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546372960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546372960?lang=zh_cn&edition=full","pubTime":"2025-06-28 04:00","pubTimestamp":1751054453,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日04时00分，Elevation Oncology, Inc.股票出现波动，股价快速下跌5.90%。截至发稿，该股报0.362美元/股，成交量78.2499万股，换手率1.32%，振幅3.90%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628040053a7217602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628040053a7217602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4139","BK4539"],"gpt_icon":0},{"id":"2542322173","title":"William Blair：下调Elevation Oncology评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2542322173","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542322173?lang=zh_cn&edition=full","pubTime":"2025-06-10 03:27","pubTimestamp":1749497232,"startTime":"0","endTime":"0","summary":"William Blair：下调Elevation Oncology(ELEV.US)评级，由优于大市调整至大市一致评级。Elevation Oncology(ELEV.US)公司简介：Elevation Oncology Inc是一家肿瘤公司，专注于基因组定义患者群体癌症治疗的靶向疗法的开发。该公司的主导项目专注于神经调节蛋白1(NRG1)融合，这是一种罕见的基因组改变，具有通过靶向HER3抑制治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610033509a7010209&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610033509a7010209&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV"],"gpt_icon":0},{"id":"2542809083","title":"Elevation Oncology, Inc.股价飙升21.91% 市值涨537.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542809083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542809083?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:31","pubTimestamp":1749475919,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时31分，Elevation Oncology, Inc.股票出现异动，股价快速拉升21.91%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Synaptogenix, Inc.涨幅较大，Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃，换手率分别为984.05%、858.41%、585.59%，振幅较大的相关个股有Elevation Oncology, Inc.、Metsera, Inc.、Jade Biosciences, Inc.，振幅分别为123.66%、122.99%、117.57%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213159a700af6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213159a700af6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"gpt_icon":0},{"id":"2541071654","title":"Elevation Oncology, Inc.盘中异动 早盘快速上涨5.13%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541071654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541071654?lang=zh_cn&edition=full","pubTime":"2025-06-05 23:00","pubTimestamp":1749135611,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日23时00分，Elevation Oncology, Inc.股票出现波动，股价快速拉升5.13%。截至发稿，该股报0.320美元/股，成交量11.5537万股，换手率0.20%，振幅6.05%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605230011a6fbeca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605230011a6fbeca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ELEV"],"gpt_icon":0},{"id":"2539654812","title":"Elevation Oncology, Inc.盘中异动 快速拉升5.69%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539654812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539654812?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:31","pubTimestamp":1748525472,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时31分，Elevation Oncology, Inc.股票出现波动，股价急速上涨5.69%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Alzamend Neuro, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Polyrizon Ltd.涨幅较大，Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为4584.43%、446.39%、237.22%，振幅较大的相关个股有Aspire Biopharma Holdings, Inc.、Sensei Biotherapeutics, Inc.、Alzamend Neuro, Inc.，振幅分别为22.95%、8.00%、7.53%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213112a4916bc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213112a4916bc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"gpt_icon":0},{"id":"2537193944","title":"Elevation Oncology, Inc.盘中异动 早盘快速下跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537193944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537193944?lang=zh_cn&edition=full","pubTime":"2025-05-21 22:09","pubTimestamp":1747836593,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日22时09分，Elevation Oncology, Inc.股票出现波动，股价快速下跌5.46%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521220953aa2c954f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521220953aa2c954f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ELEV"],"gpt_icon":0},{"id":"2536687147","title":"Elevation Oncology, Inc.盘中异动 大幅拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687147?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:39","pubTimestamp":1747661981,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时39分，Elevation Oncology, Inc.股票出现波动，股价快速拉升5.38%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213941a6e4d263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213941a6e4d263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ELEV"],"gpt_icon":0},{"id":"2536344152","title":"Elevation Oncology, Inc.盘中异动 急速下挫8.87%报0.273美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536344152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536344152?lang=zh_cn&edition=full","pubTime":"2025-05-17 02:52","pubTimestamp":1747421569,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日02时52分，Elevation Oncology, Inc.股票出现异动，股价快速下跌8.87%。截至发稿，该股报0.273美元/股，成交量101.862万股，换手率1.72%，振幅6.80%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517025249a4813ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517025249a4813ae9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"gpt_icon":0},{"id":"2535290808","title":"Elevation Oncology, Inc.盘中异动 急速下挫5.77%报0.322美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535290808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535290808?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:54","pubTimestamp":1747317285,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时54分，Elevation Oncology, Inc.股票出现异动，股价急速跳水5.77%。截至发稿，该股报0.322美元/股，成交量48.5385万股，换手率0.82%，振幅4.65%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051521544694f7ff70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051521544694f7ff70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"gpt_icon":0},{"id":"2532661080","title":"Elevation Oncology, Inc.盘中异动 下午盘股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532661080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532661080?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:23","pubTimestamp":1746033806,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时23分，Elevation Oncology, Inc.股票出现异动，股价大幅上涨5.37%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501012326974bcdab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501012326974bcdab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELEV","BK4539"],"gpt_icon":0},{"id":"2530233749","title":"Elevation Oncology, Inc.盘中异动 急速下跌5.51%报0.355美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530233749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530233749?lang=zh_cn&edition=full","pubTime":"2025-04-28 22:59","pubTimestamp":1745852340,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时59分，Elevation Oncology, Inc.股票出现异动，股价大幅下跌5.51%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Cg Oncology, Inc.、Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Springworks Therapeutics, Inc.较为活跃，换手率分别为2278.80%、443.22%、77.15%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Senti Biosciences, Inc.，振幅分别为41.40%、35.75%、22.80%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428225900a46aa671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428225900a46aa671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139"],"gpt_icon":0},{"id":"2529387620","title":"Elevation Oncology, Inc.盘中异动 股价大跌6.63%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529387620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529387620?lang=zh_cn&edition=full","pubTime":"2025-04-21 23:59","pubTimestamp":1745251173,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时59分，Elevation Oncology, Inc.股票出现波动，股价急速跳水6.63%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235933973f91a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235933973f91a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4139","BK4539"],"gpt_icon":0},{"id":"2528741162","title":"Elevation Oncology, Inc.盘中异动 快速上涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528741162?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:30","pubTimestamp":1744896641,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时30分，Elevation Oncology, Inc.股票出现异动，股价急速拉升5.84%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为336.37%、128.06%、41.88%，振幅较大的相关个股有Passage Bio, Inc.、Kyverna Therapeutics, Inc.、Lineage Cell Therapeutics, Inc.，振幅分别为9.12%、7.10%、6.96%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213041973b50e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213041973b50e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"gpt_icon":0},{"id":"2527425239","title":"Elevation Oncology, Inc.盘中异动 下午盘股价大涨5.21%报0.309美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527425239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527425239?lang=zh_cn&edition=full","pubTime":"2025-04-16 01:39","pubTimestamp":1744738798,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日01时39分，Elevation Oncology, Inc.股票出现波动，股价大幅拉升5.21%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为1401.58%、968.54%、257.13%，振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.，振幅分别为171.53%、97.08%、91.33%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416013959aa2c704b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416013959aa2c704b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ELEV"],"gpt_icon":0},{"id":"2527432261","title":"Elevation Oncology, Inc.盘中异动 股价大涨6.14%报0.297美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527432261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527432261?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:43","pubTimestamp":1744659821,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日03时43分，Elevation Oncology, Inc.股票出现异动，股价大幅拉升6.14%。截至发稿，该股报0.297美元/股，成交量49.4453万股，换手率0.84%，振幅8.79%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为2.89%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc 是一家专注于开发选择性癌症疗法的肿瘤学公司，用于治疗一系列具有未满足医疗需求的实体肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415034341a458d53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415034341a458d53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELEV","BK4539"],"gpt_icon":0},{"id":"2518276444","title":"Elevation Oncology, Inc.盘中异动 早盘股价大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276444?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615836,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，Elevation Oncology, Inc.股票出现异动，股价大幅下挫5.83%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3223.97%、699.39%、122.31%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、32.14%、30.70%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc是一家肿瘤公司，专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221037a26a3387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221037a26a3387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139"],"gpt_icon":1},{"id":"2518728106","title":"Elevation Oncology, Inc.2024财年实现净利润-44.49百万美元，同比增加2.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518728106?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536089,"startTime":"0","endTime":"0","summary":"3月10日，Elevation Oncology, Inc.公布财报，公告显示公司2024财年净利润为-44.49百万美元，同比增加2.65%；其中营业收入为0.00美元，每股基本收益为-0.78美元。机构评级：截至2025年3月10日，当前有6家机构对Elevation Oncology, Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为5.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000328a26898ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000328a26898ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV"],"gpt_icon":0},{"id":"2517709114","title":"Elevation Oncology(ELEV.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.18美元，前值为-0.19美元，预期值为-0.23美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517709114","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517709114?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:02","pubTimestamp":1741302179,"startTime":"0","endTime":"0","summary":"Elevation Oncology(ELEV.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.18美元，前值为-0.19美元，预期值为-0.23美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070248578856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ELEV"],"gpt_icon":0},{"id":"1153914229","title":"Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)","url":"https://stock-news.laohu8.com/highlight/detail?id=1153914229","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153914229?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:40","pubTimestamp":1741297240,"startTime":"0","endTime":"0","summary":"Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)以上内容来自Benzinga Earnings专栏，原文如下：Elevation Oncology Q4 2024 GAAP EPS $(0.18) Beats $(0.22) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELEV"],"gpt_icon":0},{"id":"2517946616","title":"Elevation Oncology, Inc.盘中异动 大幅拉升5.00%报0.511美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517946616?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:39","pubTimestamp":1741189154,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时39分，Elevation Oncology, Inc.股票出现波动，股价急速拉升5.00%。截至发稿，该股报0.511美元/股，成交量12.5556万股，换手率0.21%，振幅9.25%。Elevation Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。Elevation Oncology, Inc.公司简介：Elevation Oncology Inc是一家肿瘤公司，专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233914abe9c666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233914abe9c666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.elevationoncology.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1999},{"period":"6month","weight":-0.2856},{"period":"1year","weight":-0.5308},{"period":"ytd","weight":-0.3512}],"compareEarnings":[{"period":"1week","weight":-0.0076},{"period":"1month","weight":0.0298},{"period":"3month","weight":0.0744},{"period":"6month","weight":0.118},{"period":"1year","weight":0.1359},{"period":"ytd","weight":0.0925}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Elevation Oncology, Inc.于2019年4月29日根据特拉华州法律注册成立。该公司是一家创新的肿瘤学公司，专注于发现和开发选择性癌症疗法，以治疗一系列实体瘤患者，这些患者的医疗需求尚未得到满足。该公司正在重新思考药物开发，寻求创新的、选择性的癌症疗法，这些疗法可以与患者独特的肿瘤特征相匹配。该公司的主要候选产品EO-3021（也称为SYSA1801或CPO102）是一种抗体药物偶联物，旨在靶向Claudin18.2，这是一种经过临床验证的分子靶点，可选择性地将细胞毒性有效载荷直接递送至表达Claudin18.2的癌细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":1.046898},{"month":2,"riseRate":0.5,"avgChangeRate":0.054514},{"month":3,"riseRate":0.5,"avgChangeRate":0.031686},{"month":4,"riseRate":0.75,"avgChangeRate":0.182167},{"month":5,"riseRate":0.5,"avgChangeRate":0.070175},{"month":6,"riseRate":0.25,"avgChangeRate":-0.28136},{"month":7,"riseRate":0,"avgChangeRate":-0.14758},{"month":8,"riseRate":0.25,"avgChangeRate":-0.181997},{"month":9,"riseRate":0,"avgChangeRate":-0.178306},{"month":10,"riseRate":0.25,"avgChangeRate":-0.075221},{"month":11,"riseRate":0.5,"avgChangeRate":-0.038591},{"month":12,"riseRate":0.5,"avgChangeRate":-0.034245}],"exchange":"NASDAQ","name":"Elevation Oncology, Inc.","nameEN":"Elevation Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Elevation Oncology, Inc.(ELEV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Elevation Oncology, Inc.(ELEV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Elevation Oncology, Inc.,ELEV,Elevation Oncology, Inc.股票,Elevation Oncology, Inc.股票老虎,Elevation Oncology, Inc.股票老虎国际,Elevation Oncology, Inc.行情,Elevation Oncology, Inc.股票行情,Elevation Oncology, Inc.股价,Elevation Oncology, Inc.股市,Elevation Oncology, Inc.股票价格,Elevation Oncology, Inc.股票交易,Elevation Oncology, Inc.股票购买,Elevation Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Elevation Oncology, Inc.(ELEV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Elevation Oncology, Inc.(ELEV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}